Difference between revisions of "Part:BBa K2738006:Experience"

 
Line 5: Line 5:
  
 
===Applications of BBa_K2738006===
 
===Applications of BBa_K2738006===
 +
Results:
 +
Expression verification
 +
The ferritin-ovispirin fusion protein was produced via cell-free expression system. The expression was verified by SDS gel as shown in the figure below. 
 +
<img scr="https://static.igem.org/mediawiki/2018/6/6d/T--Paris_Bettencourt--BBa_K2738006.png">
 +
 +
Figure 2. Cell free expression and purification of Ferritin-ovispirin-StarCore
 +
 +
2. MIC and growth curve
 +
We determined the MIC of ferritin-ovispirin StarCore to inhibit the growth of E coli and B subtilis (figure A and B). We performed growth curve assay for E coli and B subtilis with and without antimicrobial peptides as shown in figure C and D. 
 +
 +
The results indicate that the ferritin-ovispirin StarCore has the MIC activity at 3 ug/ml for both E coli and B subtilis. Moreover, at 7.3 uM it also affects their growth kinetics to a significant extent indicating bactericidal activity. The antibacterial activity of ferritin-ovispirin StarCore is comparable to ovispirin at its MIC concentration (5 uM) alone as shown in the figure.
 +
 +
<img scr="https://static.igem.org/mediawiki/2018/4/4d/T--Paris_Bettencourt--BB_006.png">
 +
 +
3. Dynamic time-lapse imaging of bactericidal cell viability
 +
 +
The following results were obtained by time-lapse microscopy imaging, to study the bactericidal effect of antimicrobial peptides on B subtilis viability. Here we can observe that the presence of antimicrobial peptide proves to be toxic for the growing B subtilis which supports our growth curve data and MIC data. 
 +
 +
Control: <img scr="https://static.igem.org/mediawiki/2018/f/f6/T--Paris_Bettencourt--control_bsub.gif">
 +
 +
Ovispirin+Ferritin: <img scr="https://static.igem.org/mediawiki/2018/4/44/T--Paris_Bettencourt--OV1_-_bsub.gif">
 +
 +
 +
4. Biocompatibility towards mammalian cell membrane
 +
<img scr="https://static.igem.org/mediawiki/2018/1/17/T--Paris_Bettencourt--liposome_c6.png">
 +
 +
Figure 1. Mammalian liposome leakage induced by ferritin-ovispirin StarCore (A) and the kinetics of liposome leakage (B). Ovispirin (5 uM) and ferritin-ovispirin (3 uM) are used at their MIC concentration obtained from previous results.
 +
<img scr="https://static.igem.org/mediawiki/2018/1/17/T--Paris_Bettencourt--liposome_c6.png">
 +
 +
To test the biocompatibility of the StarCores with mammalian membrane, we performed liposome leakage assay. Ovispirin alone lyses the liposome indicating damage to mammalian cell membrane. Ferritin-ovispirin has a reduced effect on the liposome leakage indicating an improvement in biocompatibility towards mammalian cell membrane. The Starcore ferritin-ovispirin has a safer profile in terms of membrane activity as compared to ovispirin alone at their respective MIC concentration.
 +
 +
References:
 +
Ovispirin obtained from DRAMP database: DRAMP03826
 +
Ferritin obtained from RCSB. PDB number: 4XGS
 +
Star shaped antimicrobial peptides : 10.1038/NMICROBIOL.2016.162 
 +
  
 
===User Reviews===
 
===User Reviews===

Revision as of 00:33, 18 October 2018


This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.

Applications of BBa_K2738006

Results: Expression verification The ferritin-ovispirin fusion protein was produced via cell-free expression system. The expression was verified by SDS gel as shown in the figure below. <img scr="T--Paris_Bettencourt--BBa_K2738006.png">

Figure 2. Cell free expression and purification of Ferritin-ovispirin-StarCore

2. MIC and growth curve We determined the MIC of ferritin-ovispirin StarCore to inhibit the growth of E coli and B subtilis (figure A and B). We performed growth curve assay for E coli and B subtilis with and without antimicrobial peptides as shown in figure C and D.

The results indicate that the ferritin-ovispirin StarCore has the MIC activity at 3 ug/ml for both E coli and B subtilis. Moreover, at 7.3 uM it also affects their growth kinetics to a significant extent indicating bactericidal activity. The antibacterial activity of ferritin-ovispirin StarCore is comparable to ovispirin at its MIC concentration (5 uM) alone as shown in the figure.

<img scr="T--Paris_Bettencourt--BB_006.png">

3. Dynamic time-lapse imaging of bactericidal cell viability

The following results were obtained by time-lapse microscopy imaging, to study the bactericidal effect of antimicrobial peptides on B subtilis viability. Here we can observe that the presence of antimicrobial peptide proves to be toxic for the growing B subtilis which supports our growth curve data and MIC data.

Control: <img scr="T--Paris_Bettencourt--control_bsub.gif">

Ovispirin+Ferritin: <img scr="T--Paris_Bettencourt--OV1_-_bsub.gif">


4. Biocompatibility towards mammalian cell membrane <img scr="T--Paris_Bettencourt--liposome_c6.png">

Figure 1. Mammalian liposome leakage induced by ferritin-ovispirin StarCore (A) and the kinetics of liposome leakage (B). Ovispirin (5 uM) and ferritin-ovispirin (3 uM) are used at their MIC concentration obtained from previous results. <img scr="T--Paris_Bettencourt--liposome_c6.png">

To test the biocompatibility of the StarCores with mammalian membrane, we performed liposome leakage assay. Ovispirin alone lyses the liposome indicating damage to mammalian cell membrane. Ferritin-ovispirin has a reduced effect on the liposome leakage indicating an improvement in biocompatibility towards mammalian cell membrane. The Starcore ferritin-ovispirin has a safer profile in terms of membrane activity as compared to ovispirin alone at their respective MIC concentration.

References: Ovispirin obtained from DRAMP database: DRAMP03826 Ferritin obtained from RCSB. PDB number: 4XGS Star shaped antimicrobial peptides : 10.1038/NMICROBIOL.2016.162


User Reviews

UNIQ4b8298a0e465f7c4-partinfo-00000000-QINU UNIQ4b8298a0e465f7c4-partinfo-00000001-QINU